Last $10.84 USD
Change Today +0.24 / 2.26%
Volume 12.2K
ELOS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:49 AM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

syneron medical ltd (ELOS) Snapshot

Open
$10.70
Previous Close
$10.60
Day High
$10.93
Day Low
$10.56
52 Week High
04/2/14 - $12.88
52 Week Low
10/15/14 - $8.32
Market Cap
383.0M
Average Volume 10 Days
405.6K
EPS TTM
$0.14
Shares Outstanding
35.3M
EX-Date
--
P/E TM
76.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNERON MEDICAL LTD (ELOS)

syneron medical ltd (ELOS) Related Businessweek News

No Related Businessweek News Found

syneron medical ltd (ELOS) Details

Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products worldwide. The company develops products based on its proprietary Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and topical skin brightening products. It also develops, manufactures, and markets non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products via a system-specific skin patch. The company sells its products to dermatologists, plastic and cosmetic surgeons, other qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and to home-use consumers directly, as well as through retailers and a chain of distributors. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.

621 Employees
Last Reported Date: 03/19/14
Founded in 2000

syneron medical ltd (ELOS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

syneron medical ltd (ELOS) Key Developments

Syneron Medical Appoints Ilan Nacasch as Chief Brand Officer

Syneron Medical Ltd. announced the expansion of its management team with the appointment of Ilan Nacasch to the newly created position of Chief Brand Officer, effectively immediately. He will be responsible for global marketing and branding of all Syneron-Candela products, with a strong focus on supporting the growth of the Body Shaping business in the U.S. Prior to joining Syneron, Mr. Nacasch served as Chief Marketing Officer of SodaStream International Ltd. Prior to that, he spent 15 years at Procter & Gamble in marketing positions of increasing responsibility across a range of consumer brands in Europe and the United States. He began his career in marketing at Danone.

Syneron Medical Ltd. Provides Preliminary Guidance for the Fourth Quarter of 2014

Syneron Medical Ltd. provided preliminary guidance for the fourth quarter of 2014. For the period, the company expects to report revenue for the fourth quarter 2014 to be in the range of $72 to $74 million, representing growth compared to the year-ago quarter of between 20% and 24% on a pro-forma basis.

Syneron Medical Ltd. Enters into Multi-Year Agreement with American Medical Systems to Supply Holmium Lasers

Syneron Medical Ltd. announced the signing of a multi-year agreement with American Medical Systems (AMS) to supply holmium lasers. This agreement furthers the partnership between AMS and New Star in supplying holmium lasers for the treatment of kidney stones. The NS3000, marketed under the name StoneLigh 30, is a surgical laser device that uses the Holmium wavelength to shatter kidney stones in a minimally invasive manner through a laproscopic or endoscopic procedure. With the new US Food and Drug Administration (FDA) clearance of the NS3000, this 30W laser is positioned as a compact device with the ability to treat larger kidney stones and the precise control of stone breaking, dusting and retropulsion control that physicians want.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ELOS:US $10.84 USD +0.24

ELOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $12.93 USD -0.06
Cynosure Inc $30.99 USD +0.285
El.En. SpA €30.46 EUR +0.07
Lutronic Corp 25,250 KRW +150.00
Zeltiq Aesthetics Inc $31.93 USD +1.85
View Industry Companies
 

Industry Analysis

ELOS

Industry Average

Valuation ELOS Industry Range
Price/Earnings 67.1x
Price/Sales 1.6x
Price/Book 1.7x
Price/Cash Flow 66.1x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERON MEDICAL LTD, please visit www.syneron.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.